Ville Vuorinen
Publications
- Motor dysfunction as a primary symptom predicts poor outcome: multicenter study of glioma symptoms (2024)
- Frontiers in Oncology
(A1 Refereed original research article in a scientific journal) - Viestiikö johto vaikuttavasti? (2020)
- Lääkärilehti
(D1 Article in a professional journal) - Cranioplasty After Severe Traumatic Brain Injury: Effects of Trauma and Patient Recovery on Cranioplasty Outcome (2018)
- Frontiers in Neurology
(A1 Refereed original research article in a scientific journal) - Kahden kysymyksen menetelmä lääkärin viestinnässä (2018)
- Lääkärilehti
(A1 Refereed original research article in a scientific journal) - Lääkäri viestii, potilas oppii (2018)
- Duodecim
(A1 Refereed original research article in a scientific journal) - Hoitava viestintä - lääkärin ja potilaan keskinäisviestinnän vaikuttavuus (2017)
- Duodecim
(A2 Refereed review article in a scientific journal ) - Somatostatin receptor 2A in gliomas: Association with oligodendrogliomas and favourable outcome (2017)
- Oncotarget
(A1 Refereed original research article in a scientific journal) - Vastine edelliseen : Viestintää vai vuorovaikutusta? (2017)
- Duodecim
(D1 Article in a professional journal) - A glass fiber-reinforced composite - bioactive glass cranioplasty implant: A case study of an early development stage implant removed due to a late infection (2016)
- Journal of the Mechanical Behavior of Biomedical Materials
(A1 Refereed original research article in a scientific journal) - Outcomes of Cranioplasty with Synthetic Materials and Autologous Bone Grafts (2015)
- World Neurosurgery
(A1 Refereed original research article in a scientific journal) - Paediatric cranial defect reconstruction using bioactive fibre-reinforced composite implant: early outcomes (2015)
- Acta Neurochirurgica
(A1 Refereed original research article in a scientific journal) - Presenting symptoms of glioma in adults. (2015)
- Acta Neurologica Scandinavica
(A1 Refereed original research article in a scientific journal) - Serum levels of GFAP and EGFR in primary and recurrent high-grade gliomas: correlation to tumor volume, molecular markers, and progression-free survival (2015)
- Journal of Neuro-Oncology
(A1 Refereed original research article in a scientific journal) - Somatostatin receptor subtype 2 in high-grade gliomas: PET/CT with Ga-68-DOTA-peptides, correlation to prognostic markers, and implications for targeted radiotherapy (2015)
- EJNMMI Research
(A1 Refereed original research article in a scientific journal)